Severe vitamin D deficiency associated with BRAF-mutated melanoma

被引：4
|
作者：
Fearfield, L. [1 ]
Nobbs, J. [1 ]
Petruckevitch, A. [2 ]
Harland, C. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Dermatol, Skin & Melanoma Unit, London, England
[2] Royal Marsden Hosp, Dept Stat, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 06期
关键词：
SURVIVAL;
D O I：
10.1111/bjd.18413
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1343 / 1343
页数：1
相关论文
共 50 条
  • [1] MEK Inhibition in BRAF-Mutated Melanoma
    MacKenzie, Alex
    Boycott, Kym
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (14): : 1364 - 1365
  • [2] Vemurafenib and cobimetinib in BRAF-mutated melanoma
    Rahman, Ahmadur
    [J]. LANCET ONCOLOGY, 2014, 15 (12): : E535 - E535
  • [3] Radiosensitizing effect of BRAF inhibitors in BRAF-mutated melanoma
    Hecht, M.
    Grabenbauer, M.
    Fietkau, R.
    Distel, L. V.
    Heinzerling, L.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 35 - 35
  • [4] Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
    Larkin, James
    Ascierto, Paolo A.
    Dreno, Brigitte
    Atkinson, Victoria
    Liszkay, Gabriella
    Maio, Michele
    Mandala, Mario
    Demidov, Lev
    Stroyakovskiy, Daniil
    Thomas, Luc
    de la Cruz-Merino, Luis
    Dutriaux, Caroline
    Garbe, Claus
    Sovak, Mika A.
    Chang, Ilsung
    Choong, Nicholas
    Hack, Stephen P.
    McArthur, Grant A.
    Ribas, Antoni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (20): : 1867 - 1876
  • [5] Development of encorafenib for BRAF-mutated advanced melanoma
    Koelblinger, Peter
    Thuerigen, Olaf
    Dummer, Reinhard
    [J]. CURRENT OPINION IN ONCOLOGY, 2018, 30 (02) : 125 - 133
  • [6] The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma
    Liu, Xiao
    Wu, Jinfeng
    Qin, Haihong
    Xu, Jinhua
    [J]. TARGETED ONCOLOGY, 2018, 13 (04) : 437 - 446
  • [7] The Development of Vemurafenib for BRAF-mutated, Metastatic Melanoma
    Borellini, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S74 - S74
  • [8] Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
    Spagnolo, Francesco
    Ghiorzo, Paola
    Queirolo, Paola
    [J]. ONCOTARGET, 2014, 5 (21) : 10206 - 10221
  • [9] Treatment of BRAF-mutated advanced cutaneous melanoma
    Van Anh Trinh
    You, Yan
    Hwu, Wen-Jen
    [J]. CHINESE CLINICAL ONCOLOGY, 2014, 3 (03)
  • [10] Dabrafenib and Trametinib for BRAF-Mutated Conjunctival Melanoma
    Kim, Jenna May
    Weiss, Sarah
    Sinard, John H.
    Pointdujour-Lim, Renelle
    [J]. OCULAR ONCOLOGY AND PATHOLOGY, 2020, 6 (01) : 35 - 38
12345